| Financial Year |
March 31 2023 |
| Monetary Funds |
1,297,334,999.66 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
953,465,048.46 |
| Advances to Suppliers |
317,008,050.65 |
| Other Receivables |
35,404,554.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,475,255,907.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
97,433,982.49 |
| Total Current Assets |
4,840,136,318.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
692,316,468.99 |
| Investment Properties |
16,118,087.34 |
| Fixed Assetes |
3,488,943,863.13 |
| Under-construction Projects |
294,602,884.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
347,228,828.93 |
| R&D expenses |
5,856,280.36 |
| Goodwill |
11,547,305.29 |
| Long-Term Deferred and Prepaid Expenses |
65,053,851.71 |
| Deferred Income Tax Assets |
44,369,098.56 |
| Other Non-Current Assets |
258,503,509.31 |
| Sub-Total of Non-Current Assets |
5,266,721,873.41 |
| Total Assets |
10,106,858,191.87 |
| Short-Term Loans |
1,171,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
386,630,833.02 |
| Accounts Payable |
624,032,883.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
42,534,866.20 |
| Taxes Payable |
5,286,033.37 |
| Interest Payable |
576,777.09 |
| Dividend Payable |
-- |
| Other payables |
158,993,949.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,068,834.79 |
| Other Current Liabilities |
11,599,564.85 |
| Sub-Total of Current Liabilities |
2,503,281,299.48 |
| Long-term Loans |
359,648,500.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,091,693.12 |
| Deferred Income Tax Liabilities |
1,898,530.47 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
416,823,417.08 |
| Total Liabilities |
2,920,104,716.56 |
| Paid-In Capital(Or Share Stock) |
1,844,557,178.00 |
| Capital Surplus |
887,642,772.38 |
| Surplus Reserve |
382,328,530.90 |
| LESS:Treasury Stock |
89,868,000.00 |
| Undistributed Profits |
2,281,265,139.48 |
| Minority Stockholder's Interest |
1,884,188,414.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,302,565,060.47 |
| Owner's Equity（Stockholder's Equity） |
7,186,753,475.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,106,858,191.87 |
